Ontario-led Team Receives $4.7M from Movember to Develop Dx to Guide Prostate Cancer Treatment | GenomeWeb

NEW YORK (GenomeWeb) – A research team led by scientists at the Ontario Institute for Cancer Research have received a C$5 million (US$4.7 million) grant from the Movember Foundation to develop diagnostic molecular markers that physicians could use to make treatment decisions for their prostate cancer patients.

Called PRONTO, the project was funded by a Movember Team Grant that was awarded by Prostate Cancer Canada, PCC said on Tuesday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.